Search research articles
Contact Us
Filters
Showing results (21-30 of 56) with videos related to
Page
of 6
Sort By:
Chemical Communications (Cambridge, England)
|
November 13, 2012
γ-Selective directed catalytic asymmetric hydroboration of 1,1-disubstituted alkenes
Sean M Smith, Gia L Hoang, Rhitankar Pal, et al.
Neuropharmacology
|
June 6, 2015
The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents
Renee C Gentzel, Dawn Toolan, Rhonda Roberts, et al.
Journal of Lipid Research
|
April 30, 2022
Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes
Nanyan Rena Zhang, Nathan G Hatcher, Kim Ekroos, et al.
Plos One
|
December 31, 2024
Deciphering the interactome of Ataxin-2 and TDP-43 in iPSC-derived neurons for potential ALS targets
Yuan Tian, Nicolette Heinsinger, Yinghui Hu, et al.
Journal of Clinical Psychopharmacology
|
March 19, 2026
Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression
Aristide Merola, Yuki Mukai, Tjerk Bueters, et al.
Organic Letters
|
February 3, 2015
Enantioselective desymmetrization via carbonyl-directed catalytic asymmetric hydroboration and Suzuki-Miyaura cross-coupling
Gia L Hoang, Zhao-Di Yang, Sean M Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia
Sean M Smith, Dawn Toolan, Monika Kandebo, et al.
Plos One
|
April 7, 2018
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Xiaohai Wang, Karen Smith, Michelle Pearson, et al.
Journal of Neurochemistry
|
April 27, 2017
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine
Lihang Yao, Andres D Ramirez, Anthony J Roecker, et al.
Journal of Medicinal Chemistry
|
September 18, 2015
Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
William D Shipe, Steven S Sharik, James C Barrow, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 56) with videos related to
Sort By:
Page
of 6
Chemical Communications (Cambridge, England)
|
November 13, 2012
γ-Selective directed catalytic asymmetric hydroboration of 1,1-disubstituted alkenes
Sean M Smith, Gia L Hoang, Rhitankar Pal, et al.
Neuropharmacology
|
June 6, 2015
The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents
Renee C Gentzel, Dawn Toolan, Rhonda Roberts, et al.
Journal of Lipid Research
|
April 30, 2022
Validation of a multiplexed and targeted lipidomics assay for accurate quantification of lipidomes
Nanyan Rena Zhang, Nathan G Hatcher, Kim Ekroos, et al.
Plos One
|
December 31, 2024
Deciphering the interactome of Ataxin-2 and TDP-43 in iPSC-derived neurons for potential ALS targets
Yuan Tian, Nicolette Heinsinger, Yinghui Hu, et al.
Journal of Clinical Psychopharmacology
|
March 19, 2026
Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression
Aristide Merola, Yuki Mukai, Tjerk Bueters, et al.
Organic Letters
|
February 3, 2015
Enantioselective desymmetrization via carbonyl-directed catalytic asymmetric hydroboration and Suzuki-Miyaura cross-coupling
Gia L Hoang, Zhao-Di Yang, Sean M Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 2025
Preclinical evaluation of MK-8189: A novel phosphodiesterase 10A inhibitor for the treatment of schizophrenia
Sean M Smith, Dawn Toolan, Monika Kandebo, et al.
Plos One
|
April 7, 2018
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Xiaohai Wang, Karen Smith, Michelle Pearson, et al.
Journal of Neurochemistry
|
April 27, 2017
The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine
Lihang Yao, Andres D Ramirez, Anthony J Roecker, et al.
Journal of Medicinal Chemistry
|
September 18, 2015
Discovery and Optimization of a Series of Pyrimidine-Based Phosphodiesterase 10A (PDE10A) Inhibitors through Fragment Screening, Structure-Based Design, and Parallel Synthesis
William D Shipe, Steven S Sharik, James C Barrow, et al.
Page
of 6